Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract

By Winquist E.   Ernst D.S.   Jonker D.   Moore M.J.   Segal R.   Lockwood G.   Rodgers A.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1866-1871

Elsevier

Access to resources Recommend Favorite

Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial - an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study

By Pectasides D.   Visvikis A.   Aspropotamitis A.   Halikia A.   Karvounis N.   Dimitriadis M.   Athanassiou A.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 74-79

Elsevier

Access to resources Recommend Favorite

Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II study

By Kim J.   Millikan R.E.   Smith T.L.   Tu S.-M.   Pagliaro L.C.   Logothetis C.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 1, 2003-01 ,pp. : 21-26

Elsevier

Access to resources Recommend Favorite

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum

By Lorusso V.   Pollera C.F.   Antimi M.   Luporini G.   Gridelli C.   Frassineti G.L.   Oliva C.   Pacini M.   De Lena M.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1208-1212

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced, Persistent, or Recurrent Squamous Cell Carcinoma of the Cervix

By Burnett A.F.   Roman L.D.   Garcia A.A.   Muderspach L.I.   Brader K.R.   Morrow C.P.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 63-66

Elsevier

Access to resources Recommend Favorite